Oncology & Cancer

ASCO: No benefit for immediate ADT after PSA-only relapse

(HealthDay)—For men with a prostate-specific antigen (PSA)-only-based relapse after prostate surgery or radiation therapy, there seems to be little or no survival benefit for immediate initiation of androgen deprivation ...

Oncology & Cancer

Study identifies a key cellular pathway in prostate cancer

Mayo Clinic researchers have shed light on a new mechanism by which prostate cancer develops in men. Central to development of nearly all prostate cancer cases are malfunctions in the androgen receptor—the cellular component ...

page 22 from 32